Anti-cancer agents based on 6-trifluoromethoxybenzimidazole derivatives and method of making
申请人:The United States of America as represented by the United States Department of Energy
公开号:US08242284B1
公开(公告)日:2012-08-14
The present disclosure relates to novel compounds having the structural Formulas (1a,1b), stereoisomers, tautomers, racemics, prodrugs, metabolites thereof, or pharmaceutically acceptable salt and/or solvate thereof as chemotherapy agents for treating of cancer, particularly androgen-independent prostate cancer. The disclosure also relates to methods for preparing said compounds, and to pharmaceutical compositions comprising said compounds.
本公开涉及具有结构式(1a,1b),立体异构体,互变异构体,混合物,前药,代谢物或其药学上可接受的盐和/或溶剂的新化合物,作为化疗药物用于治疗癌症,特别是雄激素非依赖性前列腺癌。本公开还涉及制备所述化合物的方法,以及包含所述化合物的制药组合物。